不同脓毒症定义作为自动化标准的比较
该研究为单中心回顾性电子健康记录分析,纳入2012年1月1日至2018年1月6日成人非手术住院患者,共286,759次就诊符合纳入标准。应用不同脓毒症标准后,各队列患病率从CDC成人脓毒症事件(ASE)的4.4%到Sepsis-1的11.3%不等;Sepsis-3(n=21,550)与CDC ASE(n=12,494)重叠仅7,763例。各队列从入院到脓毒症发生时间、脓毒症出院ICD编码率及院内死亡率均存在差异。提示自动化脓毒症标准的选择会显著影响队列构成与质量指标解读。
要点
- 同一人群中各标准患病率:CDC ASE 4.4%、CMS severe sepsis核心指标1 4.8%、ICD编码7.2%、Sepsis-3 7.5%、Sepsis-1 11.3%。
- Sepsis-3(n=21,550)与CDC ASE(n=12,494)重叠仅7,763例,说明两项现代标准一致性低。
- 入院至脓毒症发生时间(小时):Sepsis-1 2.9、Sepsis-3 4.1、CDC ASE 4.6、CMS severe sepsis核心指标1 7.6。
- 院内死亡率:Sepsis-1 13.6%、Sepsis-3 18.8%、ICD编码20.4%、CMS severe sepsis核心指标1 22.5%、CDC ASE 24.1%。
- 脓毒症出院ICD编码率:Sepsis-1 37.4%、Sepsis-3 40.1%、CMS severe sepsis核心指标1 48.5%、CDC ASE 54.5%。
适用人群与场景
- 成人、非手术住院患者,入院时间在2012年1月1日至2018年1月6日之间,来自美国密苏里州圣路易斯市单家三级医疗中心。
- 数据来源为电子健康记录,系回顾性分析;原文未提及急诊或ICU单独场景的限定。
诊断标准与关键阈值
- 原文比较了Sepsis-1、Sepsis-3、CDC Adult Sepsis Event(成人脓毒症事件)及CMS severe sepsis核心指标1四种脓毒症定义,但未给出各定义的具体条件与界值。
- 原文未提及各标准的启动/停止阈值或评分界值。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:单中心回顾性电子健康记录数据分析;样本量286,759次就诊符合纳入标准;无干预。
- 主要结果:各标准患病率不同——CDC ASE 4.4%、CMS severe sepsis核心指标1 4.8%、ICD编码7.2%、Sepsis-3 7.5%、Sepsis-1 11.3%。
- Sepsis-3(n=21,550)与CDC ASE(n=12,494)重叠7,763例;从入院到脓毒症发生时间、脓毒症出院ICD编码率、院内死亡率在各队列间均不同。
- 院内死亡率:Sepsis-1 13.6%、Sepsis-3 18.8%、ICD编码20.4%、CMS severe sepsis核心指标1 22.5%、CDC ASE 24.1%。
- 脓毒症出院ICD编码率:Sepsis-1 37.4%、Sepsis-3 40.1%、CMS severe sepsis核心指标1 48.5%、CDC ASE 54.5%。
- 入院至脓毒症发生时间(小时):Sepsis-1 2.9、Sepsis-3 4.1、CDC ASE 4.6、CMS severe sepsis核心指标1 7.6。
证据类型、等级与局限
- 证据类型:回顾性电子健康记录数据分析(单中心)。
- 局限:单中心、回顾性设计;原文未提及更多局限。
对床旁实践的改变
- 提示床旁与质控中不宜将不同脓毒症定义筛出的队列视为等同;引用患病率、发生率或死亡率数据时需注明所用定义。
- Sepsis-3与CDC ASE重叠仅7,763例,基于不同标准的质量指标或研究结论不可直接互换。
- 原文未提及对具体治疗决策(如抗菌药物启动、液体复苏)的影响,不能据此改变处置。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Assess the impact of heterogeneity among established sepsis criteria (Sepsis-1, Sepsis-3, Centers for Disease Control and Prevention Adult Sepsis Event, and Centers for Medicare and Medicaid severe sepsis core measure 1) through the comparison of corresponding sepsis cohorts.
DESIGN: Retrospective analysis of data extracted from electronic health record.
SETTING: Single, tertiary-care center in St. Louis, MO.
PATIENTS: Adult, nonsurgical inpatients admitted between January 1, 2012, and January 6, 2018.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: In the electronic health record data, 286,759 encounters met inclusion criteria across the study period. Application of established sepsis criteria yielded cohorts varying in prevalence: Centers for Disease Control and Prevention Adult Sepsis Event (4.4%), Centers for Medicare and Medicaid severe sepsis core measure 1 (4.8%), International Classification of Disease code (7.2%), Sepsis-3 (7.5%), and Sepsis-1 (11.3%). Between the two modern established criteria, Sepsis-3 (n = 21,550) and Centers for Disease Control and Prevention Adult Sepsis Event (n = 12,494), the size of the overlap was 7,763. The sepsis cohorts also varied in time from admission to sepsis onset (hr): Sepsis-1 (2.9), Sepsis-3 (4.1), Centers for Disease Control and Prevention Adult Sepsis Event (4.6), and Centers for Medicare and Medicaid severe sepsis core measure 1 (7.6); sepsis discharge International Classification of Disease code rate: Sepsis-1 (37.4%), Sepsis-3 (40.1%), Centers for Medicare and Medicaid severe sepsis core measure 1 (48.5%), and Centers for Disease Control and Prevention Adult Sepsis Event (54.5%); and inhospital mortality rate: Sepsis-1 (13.6%), Sepsis-3 (18.8%), International Classification of Disease code (20.4%), Centers for Medicare and Medicaid severe sepsis core measure 1 (22.5%), and Centers for Disease Control and Prevention Adult Sepsis Event (24.1%).
CONCLUSIONS: The application of commonly used sepsis definitions on a single population produced sepsis cohorts with low agreement, significantly different baseline demographics, and clinical outcomes.
参考来源
- Yu SC, Betthauser KD, Gupta A, et al. Comparison of Sepsis Definitions as Automated Criteria. Crit Care Med. 2021. PMID: 33591014. doi:10.1097/CCM.0000000000004875
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。